PANCREAS: Edited by Timothy B. GardnerExpanding indications for pancreatic islet cell transplantationMiles, Carly B.; Gardner, Timothy B.Author Information Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA Correspondence to Timothy B. Gardner, MD, MS, Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, USA. Tel: +1 603 650 6472; fax: +1 603 650 5225; e-mail: email@example.com Current Opinion in Gastroenterology: September 2020 - Volume 36 - Issue 5 - p 452-455 doi: 10.1097/MOG.0000000000000660 Buy Metrics Abstract Purpose of review We aimed to summarize the current state of performing pancreatic islet autotransplantation (IAT) for indications other than total pancreatectomy for chronic pancreatitis. Recent findings The current article will review expanded indications for IAT including partial pancreatectomy for benign inflammatory disease, trauma, pancreatic islet cell tumor and pancreatic adenocarcinoma. In the context of more access for IAT as more centers are offering this clinical service, these expanded indications will continue to push the limits of our ability to make IAT accessible. Summary Pancreatic islet cell transplantation is increasingly being used for new indications related to benign disease and malignancy. We expect continued expansion of its use as IAT becomes more accessible. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.